Commentary

Modavoxs (MDVX) Internet Talk Radio Division Announces Record Month in December

Company launches new ‘Go-Green’ network; adds six former NFL players to its sports network roster of hosts.

• Currently 0/5 Stars.
• 1
• 2
• 3
• 4
• 5

Nexia Holdings Inc. (NXHD) Eyes Better Advertising and Marketing Push for 2009

CEO wants shareholders, employees and customers to be aware of some of the unique and traditional marketing efforts that have occurred throughout 2008 and how the company plans to improve upon those efforts in 2009.

• Currently 0/5 Stars.
• 1
• 2
• 3
• 4
• 5

Kiwibox Anticipates Further Growth in 2009

Company optimistic of building upon its 15-fold rise in memberships.

• Currently 5/5 Stars.
• 1
• 2
• 3
• 4
• 5

China Gengsheng Minerals Inc. (CHGS) Achieves AAA Credit Rating

Zhengzhou City grants the company highest credit worthiness rating through a vote of confidence among Henan Province’s three influential business groups.

• Currently 0/5 Stars.
• 1
• 2
• 3
• 4
• 5

Urigen Pharmaceuticals Inc. (URGP) amends License Agreement with University of California at San Diego for URG101

Amending its license with UCSD is an important step in re-organizing and re-focusing company efforts to enhance shareholder value.

• Currently 0/5 Stars.
• 1
• 2
• 3
• 4
• 5

National Holdings (NHLD) Reports Record Revenues for FY2008

Net income drops; CEO says company operating in difficult environment.

• Currently 2.5/5 Stars.
• 1
• 2
• 3
• 4
• 5

Composite Technology's (CPTC) DeWind Ships Turbines to Complete Chile Order

Company back on track to resume backlog fulfillment reinitiated by Far East Composite Technology.

• Currently 3/5 Stars.
• 1
• 2
• 3
• 4
• 5

Communications Intelligence (CICI) Named as One of the 'Hot Banking Tech Companies to Watch in 2009'

Forrester Research reports strong trends favoring the need for the company’s products and services.

• Currently 3/5 Stars.
• 1
• 2
• 3
• 4
• 5

China Biopharma (CHBO) Issues Update of its Operations

Company reiterates its restructuring, acquisition and merger initiatives; management expects 25% revenue growth next year.

• Currently 3/5 Stars.
• 1
• 2
• 3
• 4
• 5

Provectus Pharmaceuticals Inc. (PVCT) Expands Multi-center Study of its Lead Oncology Agent PV-10

Seventh clinical trial site located at the University of Louisville continues evaluation of additional subjects for PV-10.

• Currently 0/5 Stars.
• 1
• 2
• 3
• 4
• 5